baclofen Indications/Contra | FAERs | Orange Book | BioActivity |

Stem definitionDrug idCAS RN
282 1134-47-0

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • baclofen
  • baclon
  • lioresal
  • DL-Baclofen
A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.
  • Molecular weight: 213.66
  • Formula: C10H12ClNO2
  • CLOGP: -0.62
  • LIPINSKI: 0
  • HAC: 3
  • HDO: 2
  • TPSA: 63.32
  • ALOGS: -2.48
  • ROTB: 4

Drug dosage:

DoseUnitRoute
50 mg O
0.55 mg P

Approvals:

DateAgencyCompanyOrphan
Nov. 22, 1977 FDA

FDA Adverse Event Reporting System

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Muscle spasticity 8988.88 44.15 1471 9255 1265 3373868
Drug withdrawal syndrome 5121.05 44.15 1163 9563 10622 3364511
Hypertonia 4411.63 44.15 768 9958 1222 3373911
Overdose 2258.22 44.15 771 9955 33207 3341926
Implant site infection 2230.56 44.15 368 10358 313 3374820
Pain 1671.76 44.15 762 9964 70795 3304338
Muscle spasms 1645.17 44.15 575 10151 26328 3348805
Hypotonia 1612.20 44.15 352 10374 2519 3372614
Implant site extravasation 1599.97 44.15 253 10473 105 3375028
Therapy non-responder 1548.73 44.15 443 10283 10366 3364767
Therapeutic response decreased 1472.35 44.15 425 10301 10273 3364860
Somnolence 1290.74 44.15 505 10221 31699 3343434
Complication associated with device 1276.22 44.15 343 10383 6295 3368838
Drug ineffective 1207.84 44.15 719 10007 115371 3259762
Coma 1109.71 44.15 355 10371 12197 3362936
Mental status changes 1051.05 44.15 324 10402 9823 3365310
Withdrawal syndrome 1045.19 44.15 269 10457 4125 3371008
Toxicity to various agents 1017.99 44.15 477 10249 46577 3328556
Completed suicide 960.29 44.15 405 10321 30709 3344424
Underdose 905.31 44.15 264 10462 6570 3368563
Device failure 860.52 44.15 206 10520 2295 3372838
Device malfunction 806.01 44.15 220 10506 4264 3370869
Seizure 776.20 44.15 378 10348 40022 3335111
Cerebrospinal fluid leakage 770.86 44.15 134 10592 200 3374933
Wound dehiscence 758.53 44.15 163 10563 1061 3374072
Infection 740.82 44.15 318 10408 25084 3350049
Muscle tightness 731.26 44.15 179 10547 2202 3372931
Pruritus 729.03 44.15 380 10346 46453 3328680
Condition aggravated 699.47 44.15 349 10377 38884 3336249
Confusional state 692.12 44.15 343 10383 37655 3337478
Unresponsive to stimuli 639.45 44.15 210 10516 7798 3367335
Intracranial hypotension 638.78 44.15 112 10614 181 3374952
Pyrexia 633.61 44.15 421 10305 80694 3294439
Clonus 558.60 44.15 120 10606 778 3374355
Device connection issue 549.00 44.15 93 10633 106 3375027
Implant site erosion 537.57 44.15 83 10643 17 3375116
Device dislocation 515.21 44.15 174 10552 7042 3368091
Intentional overdose 514.66 44.15 212 10514 15013 3360120
Agitation 509.76 44.15 227 10499 19479 3355654
Depressed level of consciousness 496.71 44.15 191 10535 11274 3363859
Implant site swelling 490.47 44.15 89 10637 193 3374940
Hyperhidrosis 485.76 44.15 232 10494 23378 3351755
Lethargy 462.92 44.15 192 10534 13823 3361310
Urinary tract infection 454.48 44.15 243 10483 31085 3344048
Sedation 446.84 44.15 150 10576 5951 3369182
Implant site discharge 439.43 44.15 72 10654 54 3375079
Hypotension 436.80 44.15 278 10448 49236 3325897
Medical device site infection 435.38 44.15 70 10656 39 3375094
Device breakage 422.21 44.15 127 10599 3505 3371628
Device related infection 414.19 44.15 135 10591 4876 3370257
Vomiting 413.30 44.15 339 10387 89192 3285941
Fall 406.97 44.15 284 10442 58599 3316534
Musculoskeletal stiffness 406.94 44.15 175 10551 13775 3361358
Tachycardia 406.88 44.15 205 10521 23166 3351967
Device damage 403.03 44.15 72 10654 137 3374996
Respiratory depression 402.68 44.15 124 10602 3710 3371423
Tremor 390.39 44.15 212 10514 27932 3347201
Meningitis 378.80 44.15 99 10627 1604 3373529
Device occlusion 374.52 44.15 96 10630 1435 3373698
Delirium 355.65 44.15 143 10583 9485 3365648
Dystonia 350.22 44.15 111 10615 3656 3371477
Device issue 344.53 44.15 125 10601 6251 3368882
Respiratory arrest 342.62 44.15 146 10580 11222 3363911
Hallucination 339.25 44.15 152 10574 13188 3361945
Seroma 338.94 44.15 69 10657 329 3374804
Headache 326.43 44.15 300 10426 91680 3283453
Device infusion issue 322.40 44.15 61 10665 181 3374952
Muscular weakness 320.74 44.15 167 10559 20174 3354959
Death 320.65 44.15 375 10351 151949 3223184
Suicide attempt 317.27 44.15 153 10573 15694 3359439
Device leakage 309.34 44.15 80 10646 1240 3373893
Cardiac arrest 308.72 44.15 180 10546 27139 3347994
Hypertension 302.00 44.15 201 10525 38265 3336868
Decubitus ulcer 299.90 44.15 86 10640 1996 3373137
Staphylococcal infection 294.76 44.15 121 10605 8458 3366675
Device battery issue 291.76 44.15 47 10679 27 3375106
Implant site pain 290.25 44.15 71 10655 866 3374267
Muscle rigidity 288.62 44.15 91 10635 2943 3372190
Device alarm issue 286.83 44.15 55 10671 179 3374954
Pocket erosion 286.60 44.15 44 10682 7 3375126
Irritability 285.74 44.15 128 10598 11088 3364045
Nausea 283.88 44.15 326 10400 129319 3245814
Loss of consciousness 275.24 44.15 169 10557 27978 3347155
Asthenia 274.02 44.15 235 10491 65430 3309703
Poisoning deliberate 273.56 44.15 69 10657 962 3374171
Respiratory failure 265.39 44.15 154 10572 22987 3352146
Insomnia 263.55 44.15 180 10546 35718 3339415
Bradycardia 263.09 44.15 137 10589 16532 3358601
Device power source issue 259.15 44.15 40 10686 8 3375125
Implant site erythema 257.56 44.15 53 10673 269 3374864
Device kink 251.87 44.15 63 10663 847 3374286
Infusion site mass 244.46 44.15 44 10682 89 3375044
Hypothermia 242.99 44.15 81 10645 3134 3371999
Malaise 239.33 44.15 217 10509 64960 3310173
Back pain 229.08 44.15 169 10557 37836 3337297
Post lumbar puncture syndrome 221.27 44.15 43 10683 153 3374980
Poisoning 220.49 44.15 85 10641 5027 3370106
Toxic encephalopathy 220.16 44.15 61 10665 1243 3373890
Unevaluable event 219.33 44.15 112 10614 12964 3362169
Gait disturbance 213.99 44.15 144 10582 27848 3347285
Sepsis 211.05 44.15 151 10575 32222 3342911
Respiratory disorder 210.85 44.15 86 10640 5904 3369229
Dyskinesia 207.62 44.15 90 10636 7195 3367938
Altered state of consciousness 207.23 44.15 84 10642 5674 3369459
Pneumonia aspiration 206.70 44.15 89 10637 6999 3368134
Medical device site discharge 206.00 44.15 32 10694 8 3375125
Disorientation 203.65 44.15 98 10628 9981 3365152
Off label use 202.49 44.15 182 10544 53795 3321338
Anxiety 194.48 44.15 156 10570 39473 3335660
Asphyxia 193.40 44.15 57 10669 1459 3373674
Hospitalisation 191.19 44.15 120 10606 20605 3354528
Medical device site swelling 186.88 44.15 29 10697 7 3375126
Therapy cessation 185.76 44.15 69 10657 3680 3371453
Encephalopathy 183.08 44.15 83 10643 7379 3367754
Pneumonia 181.56 44.15 193 10533 69950 3305183
Discomfort 180.55 44.15 79 10647 6457 3368676
Urinary retention 178.77 44.15 82 10644 7490 3367643
Postoperative wound infection 172.36 44.15 52 10674 1445 3373688
Scoliosis 172.21 44.15 49 10677 1103 3374030
Granuloma 172.11 44.15 47 10679 905 3374228
Autonomic nervous system imbalance 168.13 44.15 43 10683 635 3374498
Staphylococcus test positive 163.65 44.15 44 10682 797 3374336
Wound 161.27 44.15 60 10666 3213 3371920
Purulent discharge 159.67 44.15 47 10679 1197 3373936
Respiratory distress 158.71 44.15 78 10648 8310 3366823
Hypoaesthesia 154.83 44.15 113 10613 24826 3350307
Medical device site erythema 151.49 44.15 24 10702 10 3375123
Cardio-respiratory arrest 151.45 44.15 93 10633 15347 3359786
Drug hypersensitivity 151.08 44.15 129 10597 35551 3339582
Accidental overdose 149.19 44.15 71 10655 7047 3368086
Heart rate increased 149.13 44.15 90 10636 14396 3360737
Implant site haematoma 148.89 44.15 27 10699 58 3375075
Disinhibition 147.50 44.15 37 10689 503 3374630
Incorrect dose administered 147.26 44.15 88 10638 13826 3361307
Pain in extremity 144.48 44.15 145 10581 49067 3326066
Multiple sclerosis 143.34 44.15 68 10658 6700 3368433
Medical device site erosion 142.85 44.15 22 10704 4 3375129
Muscle twitching 140.70 44.15 57 10669 3840 3371293
Sleep apnoea syndrome 140.66 44.15 55 10671 3375 3371758
Paraesthesia 140.48 44.15 111 10615 27437 3347696
Abnormal behaviour 139.96 44.15 76 10650 9952 3365181
Cognitive disorder 139.42 44.15 70 10656 7804 3367329
Euphoric mood 138.32 44.15 45 10681 1609 3373524
Post procedural complication 136.46 44.15 60 10666 4957 3370176
Generalised tonic-clonic seizure 135.11 44.15 69 10657 7973 3367160
Mania 134.81 44.15 56 10670 4022 3371111
Implant site reaction 134.31 44.15 28 10698 153 3374980
Performance status decreased 130.02 44.15 40 10686 1188 3373945
Constipation 127.54 44.15 110 10616 30702 3344431
Drug effect decreased 127.42 44.15 76 10650 11893 3363240
Device computer issue 126.64 44.15 23 10703 50 3375083
Areflexia 126.22 44.15 37 10689 928 3374205
Scar 125.15 44.15 47 10679 2582 3372551
Implant site scar 125.15 44.15 25 10701 106 3375027
Respiratory rate decreased 124.19 44.15 36 10690 867 3374266
Dizziness 124.11 44.15 166 10560 76346 3298787
Neurotoxicity 123.37 44.15 50 10676 3371 3371762
Urinary incontinence 123.03 44.15 59 10667 5953 3369180
Medical device site pain 122.37 44.15 22 10704 44 3375089
Hyporeflexia 121.75 44.15 34 10692 713 3374420
Incorrect drug administration rate 121.40 44.15 32 10694 535 3374598
Speech disorder 121.32 44.15 67 10659 9065 3366068
Impaired healing 120.75 44.15 61 10665 6887 3368246
Pseudomeningocele 120.37 44.15 20 10706 18 3375115
Blood creatine phosphokinase increased 119.04 44.15 75 10651 12938 3362195
Incision site complication 118.99 44.15 27 10699 231 3374902
Device inversion 117.98 44.15 18 10708 2 3375131
Hyperthermia 117.32 44.15 44 10682 2408 3372725
Apnoea 116.46 44.15 44 10682 2458 3372675
Medical device discomfort 113.92 44.15 32 10694 686 3374447
Miosis 112.76 44.15 41 10685 2055 3373078
Gait inability 110.49 44.15 59 10667 7466 3367667
Status epilepticus 108.33 44.15 46 10680 3489 3371644
Medical device site fibrosis 107.36 44.15 17 10709 7 3375126
Dysarthria 107.31 44.15 63 10663 9571 3365562
Incision site erythema 106.30 44.15 21 10705 83 3375050
Incorrect route of drug administration 104.42 44.15 61 10665 9182 3365951
Device extrusion 104.40 44.15 19 10707 42 3375091
Dysphagia 101.89 44.15 80 10646 19571 3355562
Movement disorder 100.14 44.15 44 10682 3627 3371506
Macrophages increased 94.50 44.15 16 10710 18 3375115
Restlessness 94.49 44.15 53 10673 7385 3367748
Disease complication 93.88 44.15 29 10697 873 3374260
Cancer pain 93.16 44.15 25 10701 449 3374684
Autonomic dysreflexia 92.31 44.15 16 10710 23 3375110
Muscle contracture 92.08 44.15 25 10701 470 3374663
Depression 91.45 44.15 103 10623 39667 3335466
Coma scale abnormal 90.57 44.15 30 10696 1135 3373998
CSF culture positive 89.67 44.15 16 10710 30 3375103
Electroencephalogram abnormal 89.55 44.15 31 10695 1344 3373789
Medical device site reaction 89.33 44.15 16 10710 31 3375102
Adverse drug reaction 88.50 44.15 55 10671 9256 3365877
Mental disorder 88.05 44.15 47 10679 5940 3369193
Injury 87.50 44.15 55 10671 9442 3365691
Incoherent 85.96 44.15 31 10695 1517 3373616
Paralysis 85.82 44.15 36 10690 2648 3372485
Hypoventilation 85.41 44.15 28 10698 1025 3374108
Drug abuse 85.18 44.15 70 10656 18260 3356873
Urosepsis 84.88 44.15 36 10690 2721 3372412
Rhabdomyolysis 83.61 44.15 65 10661 15664 3359469
Hallucination, visual 82.78 44.15 41 10685 4435 3370698
Mydriasis 82.73 44.15 36 10690 2898 3372235
Fatigue 82.41 44.15 166 10560 107074 3268059
Alcohol poisoning 81.14 44.15 25 10701 746 3374387
Central nervous system infection 80.89 44.15 19 10707 192 3374941
Treatment noncompliance 80.39 44.15 51 10675 8894 3366239
Memory impairment 79.98 44.15 62 10664 14876 3360257
Skin erosion 79.21 44.15 23 10703 557 3374576
Incorrect dose administered by device 78.89 44.15 21 10705 365 3374768
Bradypnoea 78.79 44.15 21 10705 367 3374766
Incision site vesicles 78.61 44.15 13 10713 11 3375122
Posturing 77.76 44.15 19 10707 230 3374903
Loss of personal independence in daily activities 76.45 44.15 41 10685 5229 3369904
Wound infection 76.38 44.15 30 10696 1861 3373272
Medical device change 76.26 44.15 17 10709 133 3375000
Delusion 76.21 44.15 36 10690 3509 3371624
Feeling abnormal 75.00 44.15 78 10648 27447 3347686
Wound infection staphylococcal 74.80 44.15 22 10704 558 3374575
Purulence 74.76 44.15 22 10704 559 3374574
Sinus bradycardia 74.75 44.15 35 10691 3344 3371789
Therapeutic response unexpected 74.39 44.15 40 10686 5128 3370005
Wound secretion 74.04 44.15 25 10701 1004 3374129
Scratch 73.64 44.15 25 10701 1021 3374112
Swelling 72.73 44.15 65 10661 18979 3356154
Incision site oedema 71.66 44.15 13 10713 28 3375105
Priapism 69.70 44.15 25 10701 1204 3373929
Hypoxia 69.50 44.15 48 10678 9643 3365490
Blood pressure decreased 68.84 44.15 55 10671 13781 3361352
Hypoxic-ischaemic encephalopathy 68.01 44.15 26 10700 1499 3373634
Procedural complication 67.88 44.15 29 10697 2231 3372902
Brain injury 67.32 44.15 26 10700 1541 3373592
Ataxia 65.18 44.15 34 10692 4098 3371035
Implant site cellulitis 65.09 44.15 13 10713 55 3375078
Device ineffective 64.94 44.15 14 10712 92 3375041
General physical health deterioration 64.61 44.15 63 10663 20526 3354607
Myoclonus 64.27 44.15 33 10693 3850 3371283
Neck pain 64.23 44.15 44 10682 8723 3366410
Blood ethanol increased 63.92 44.15 14 10712 100 3375033
Diplopia 63.88 44.15 36 10690 5058 3370075
Implant site ulcer 63.23 44.15 10 10716 4 3375129
Implant site abscess 63.05 44.15 12 10714 37 3375096
Heart rate decreased 62.69 44.15 36 10690 5242 3369891
Blood pressure increased 62.35 44.15 64 10662 22166 3352967
Pre-existing disease 62.21 44.15 15 10711 171 3374962
Device electrical finding 61.90 44.15 10 10716 6 3375127
Muscle contractions involuntary 61.80 44.15 21 10705 860 3374273
Haemodynamic instability 61.63 44.15 26 10700 1939 3373194
Arachnoiditis 61.51 44.15 15 10711 180 3374953
Road traffic accident 61.01 44.15 39 10687 6887 3368246
Paranoia 58.73 44.15 31 10695 3828 3371305
Post procedural infection 58.64 44.15 23 10703 1421 3373712
Amnesia 58.45 44.15 45 10681 10681 3364452
Arteriosclerosis coronary artery 57.97 44.15 28 10698 2866 3372267
Aspiration 57.66 44.15 28 10698 2900 3372233
Onychomycosis 57.63 44.15 19 10707 708 3374425
Device material issue 57.30 44.15 11 10715 36 3375097
Burning sensation 56.66 44.15 41 10685 8863 3366270
Medical device site inflammation 56.63 44.15 9 10717 4 3375129
Wound drainage 56.07 44.15 15 10711 266 3374867
Disturbance in attention 55.25 44.15 39 10687 8109 3367024
Hyperreflexia 55.22 44.15 21 10705 1193 3373940
Metabolic encephalopathy 54.33 44.15 19 10707 849 3374284
CSF pressure decreased 54.22 44.15 9 10717 8 3375125
Aggression 53.96 44.15 44 10682 11341 3363792
Posture abnormal 53.78 44.15 18 10708 703 3374430
Stupor 53.11 44.15 20 10706 1106 3374027
Dyspnoea 52.94 44.15 136 10590 102798 3272335
Psychotic disorder 52.82 44.15 39 10687 8695 3366438
Catheter site related reaction 52.78 44.15 13 10713 163 3374970
Intentional self-injury 52.75 44.15 32 10694 5153 3369980
Therapy change 52.61 44.15 19 10707 933 3374200
Hypersomnia 52.17 44.15 27 10699 3202 3371931
Implant site vesicles 52.02 44.15 10 10716 33 3375100
Erythema 51.99 44.15 66 10660 28744 3346389
Sudden death 51.85 44.15 30 10696 4430 3370703
White blood cell count increased 51.60 44.15 45 10681 12715 3362418
Acute respiratory failure 51.22 44.15 30 10696 4532 3370601
Mobility decreased 50.45 44.15 40 10686 9908 3365225
Implant site inflammation 50.42 44.15 11 10715 77 3375056
Anal incontinence 50.06 44.15 24 10702 2416 3372717
Implant site mass 49.94 44.15 10 10716 43 3375090
Tachypnoea 49.71 44.15 27 10699 3529 3371604
Skin disorder 47.84 44.15 29 10697 4664 3370469
Implant site oedema 47.72 44.15 9 10717 26 3375107
Abdominal pain 47.23 44.15 81 10645 46144 3328989
Adhesion 46.94 44.15 14 10712 373 3374760
Meningitis bacterial 46.31 44.15 14 10712 391 3374742
Pupil fixed 45.72 44.15 16 10710 716 3374417
Device physical property issue 45.57 44.15 11 10715 126 3375007
Bacterial test positive 45.21 44.15 17 10709 936 3374197
Conjunctival hyperaemia 44.92 44.15 17 10709 953 3374180
Therapeutic response changed 44.64 44.15 13 10713 318 3374815
Abdominal rigidity 44.23 44.15 14 10712 457 3374676

Pharmacologic Action:

SourceCodeDescription
ATC M03BX01 MUSCULO-SKELETAL SYSTEM
MUSCLE RELAXANTS
MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Other centrally acting agents
CHEBI has role CHEBI:51371 muscle relaxant
CHEBI has role CHEBI:35488 central nervous system depressant
CHEBI has role CHEBI:51373 GABA agonist
FDA MoA N0000000196 GABA A Agonists
FDA MoA N0000000116 GABA B Agonists
FDA EPC N0000175759 gamma-Aminobutyric Acid-ergic Agonist
MeSH PA D002491 Central Nervous System Agents
MeSH PA D018682 GABA Agents
MeSH PA D018755 GABA Agonists
MeSH PA D058786 GABA-B Receptor Agonists
MeSH PA D009125 Muscle Relaxants, Central
MeSH PA D009465 Neuromuscular Agents
MeSH PA D018377 Neurotransmitter Agents
MeSH PA D018373 Peripheral Nervous System Agents

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Muscle spasticity of spinal origin indication 416830008
Muscle Spasticity of Cerebral Origin indication
Trigeminal neuralgia off-label use 31681005 DOID:12098
Disorder of autonomic nervous system contraindication 15241006
Schizophrenia contraindication 58214004
Psychotic disorder contraindication 69322001
Epilepsy contraindication 84757009 DOID:1826
Kidney disease contraindication 90708001 DOID:2527
Autonomic dysreflexia contraindication 129618003
Cerebrovascular accident contraindication 230690007 DOID:6713
Functional disorder of bladder neck and sphincter mechanism contraindication 236644005
Impaired cognition contraindication 386806002
Central nervous system depression contraindication 418072004

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 3.95 acidic
pKa2 9.54 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
GABA-B receptor GPCR AGONIST IC50 7.46 CHEMBL CHEMBL
Adenosine receptor A3 GPCR IC50 7.30 CHEMBL
GABA B receptor GPCR IC50 7.52 CHEMBL
GABA-A receptor; anion channel Ion channel IC50 7.52 CHEMBL

External reference:

IDSource
DB00181 DRUGBANK_ID
1084 IUPHAR_LIGAND_ID
4018392 VUID
N0000146719 NUI
C0004609 UMLSCUI
D00241 KEGG_DRUG
CHEMBL701 ChEMBL_ID
2284 PUBCHEM_CID
4018392 VANDF
N0000146719 NDFRT
N0000006613 NDFRT
001677 NDDF
709 MMSL
1292 RXNORM
387342009 SNOMEDCT_US
6102009 SNOMEDCT_US
4243 MMSL
d00967 MMSL
CHEBI:2972 CHEBI
H789N3FKE8 UNII
2956 INN_ID
D001418 MESH_DESCRIPTOR_UI
2C0 PDB_CHEM_ID

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0172-4096 TABLET 10 mg ORAL ANDA 11 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0172-4097 TABLET 20 mg ORAL ANDA 11 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0527-1330 TABLET 10 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0527-1337 TABLET 20 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0603-2406 TABLET 10 mg ORAL ANDA 13 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0603-2407 TABLET 20 mg ORAL ANDA 13 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0615-3541 TABLET 10 mg ORAL ANDA 11 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0615-3542 TABLET 20 mg ORAL ANDA 11 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0832-1024 TABLET 10 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0832-1025 TABLET 20 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0832-1054 TABLET 10 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0832-1055 TABLET 20 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0904-3365 TABLET 10 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0904-5222 TABLET 20 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0904-6475 TABLET 10 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 0904-6476 TABLET 20 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 10135-532 TABLET 10 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 10135-533 TABLET 20 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 10544-172 TABLET 10 mg ORAL ANDA 12 sections
Equipto - Baclofen External Cream Compounding Kit HUMAN PRESCRIPTION DRUG LABEL 1 15455-0701 KIT 1 g TOPICAL unapproved drug other 6 sections
Gapeam Budibac HUMAN PRESCRIPTION DRUG LABEL 7 15455-0717 KIT 1 g TOPICAL unapproved drug other 5 sections
BACLOFEN HUMAN PRESCRIPTION DRUG LABEL 1 16590-026 TABLET 10 mg ORAL ANDA 11 sections
BACLOFEN HUMAN PRESCRIPTION DRUG LABEL 1 16590-027 TABLET 20 mg ORAL ANDA 11 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 16714-071 TABLET 10 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 16714-072 TABLET 20 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 17856-1024 TABLET 10 mg ORAL ANDA 12 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 21695-014 TABLET 10 mg ORAL ANDA 13 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 21695-015 TABLET 20 mg ORAL ANDA 13 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 33261-010 TABLET 10 mg ORAL ANDA 13 sections
Baclofen HUMAN PRESCRIPTION DRUG LABEL 1 33261-011 TABLET 20 mg ORAL ANDA 13 sections